Halim is recognized by the medical community as well as regulators for his expertise and contributions to precision medicine and diagnostic development.Īt Acutis, Dr. One of only four laboratory scientists in the country to be triple board-certified, Dr. Halim is a globally recognized expert in cancer molecular profiling, precision drug development and diagnostic biomarker development with over 25 years of experience. Halim brings exemplifies our commitment to the Acutis vision. During his career, Jibreel has spent over five years working internationally in France, Canada, the United Kingdom, Singapore, Malaysia, Oman, and Saudi Arabia, amongst other countries.Ībdel Halim PharmD, MSc, PhD, DABCC, FAACC has joined as Chief Scientific Officer and Executive Vice President for biopharma and diagnostics services. Jibreel holds a Bachelors's degree in Industrial Engineering from Columbia University and a Master's degree in Business Administration from Columbia University. His early corporate experiences are as a vice president with JPMorganChase and associate director and early employee for Scient, a Silicon Valley-backed start-up that went on to a successful IPO. Most recently, Jibreel was co-founder and Executive Vice President of CGI, a joint venture with a multilateral bank. Jibreel’s work in healthcare follows his career in specialty finance and business advisory. Jibreel is a hands-on executive who takes pride in working closely with members of the healthcare community, while also being engaged in issues that directly affect the health of the general public. Today, he leads the company into the more sophisticated specialty of molecular diagnostics and into a forward-looking, research-driven firm with the introduction of Acutis Reveal™, our line of infectious disease tests, and an exciting roadmap of new diagnostics. Jibreel is driven every day to maintain Acutis’ steadfast emphasis on ease of use, speed, and accuracy. He brings over two decades of global experience to Acutis as its founding CEO. This assay is to be ordered under the guidelines issued by CDC and various departments of health to identify the presence of the virus in symptomatic patients who have tested negative for other respiratory viruses.Jibreel is passionate about improving care with the convergence of science, technology, and service. The Acutis SARS-CoV-2 test is a multiplex assay that targets three key genes-ORF1ab, N, and E, that scientists believe are key to accurately identifying the presence of the virus in patient samples. We are thankful to our development partners who have worked diligently along with our scientists, not only in providing some of the key validation material but also in ensuring us that they will be able to keep up with the demand that we have been seeing nationwide." This process, whereby we performed prescribed validation steps using various sample types, provided us with a deeper understanding of the assay than we might have experienced otherwise. "While offering an assay based on an EUA obtained by a diagnostic manufacturer rather pursuing our own might have been simpler, our team felt that by using our skill set honed in the design of our other molecular assays, it would allow us to provide the most effective solution to our clients. "We are very proud of our outstanding research and development team who have worked tirelessly on this validation," commented Jibreel Sarij, CEO. The assay will use a standard nasopharyngeal specimen from which Acutis will extract viral RNA and then test for the presence of key genes that can be used to identify its presence. The assay will be available beginning Monday, Maand will be run under an Emergency Use Authorization granted to Acutis from the FDA. EAST NORTHPORT, N.Y., Ma/PRNewswire-PRWeb/ - Acutis Diagnostics, a clinical diagnostics laboratory headquartered in New York, announced today that it has released a multiplex laboratory test for the detection of SARS-CoV-2, the causative agent of COVID-19.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |